Sana: Overview of Fourth Quarter Financial Results

Sana Biotechnology Reports Fourth Quarter Financial Results

Sana Biotechnology Inc., headquartered in Seattle, announced on Tuesday that it recorded a net loss of $58.8 million for the fourth quarter.

The company reported a per-share loss of $0.21. When excluding one-time expenses, the adjusted loss was $0.16 per share.

These figures did not meet analysts’ projections. According to a survey of six analysts by Zacks Investment Research, the consensus estimate was a loss of $0.13 per share.

—